Loading...
Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
Russell, Mark D. Dey, Mrinalini Flint, Julia Davie, Philippa Allen, Alexander Crossley, Amy Frishman, Margreta Gayed, Mary Hodson, Kenneth Khamashta, Munther
Russell, Mark D.
Dey, Mrinalini
Flint, Julia
Davie, Philippa
Allen, Alexander
Crossley, Amy
Frishman, Margreta
Gayed, Mary
Hodson, Kenneth
Khamashta, Munther
Abstract
An Executive Summary of the British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
MIDER Authors
Affiliations
South Warwickshire University NHS Foundation Trust; et al.
Citations
Altmetric:
Date
2023-04
Type
Guideline
Files
Loading...
Main article
Adobe PDF, 404.64 KB
Citation
Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, Frishman M, Gayed M, Hodson K, Khamashta M, Moore L, Panchal S, Piper M, Reid C, Saxby K, Schreiber K, Senvar N, Tosounidou S, van de Venne M, Warburton L, Williams D, Yee CS, Gordon C, Giles I; BSR Standards, Audit and Guidelines Working Group. Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2023 Apr 3;62(4):1370-1387. doi: 10.1093/rheumatology/keac558.